🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06098482
Recruiting Not applicable

An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App

NCT06098482 · tracked via the Priya Life Science USA tracker
Sponsor
Cochlear
Phase
Not applicable
Started
2024-02-05
Last updated
2025-04-30

Condition(s) studied

Hearing Loss

Investigational drug(s) / intervention(s)

Mobile Research App (MRA)SOC/validated delivery of the speech perception test material

Mobile Research App (MRA): The MRA (research tool) is a platform used for the delivery of speech perception material in-clinic outside the sound booth or in the home of the hearing-impaired recipients. The MRA speech testing module delivers speech material via streaming to the single implanted ears of cochlear implant recipients. The recipient listens to the speech material and responds with what was heard via the app. Speech is streamed via Bluetooth from the iOS device to the sound processor of the CI-recipient.

SOC/validated delivery of the speech perception test material: This involves the delivery of speech perception test material in the sound booth in a clinic.

Study summary

The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults 18 years of age or older. * Uses a hearing device or devices (hearing aid/s and/or cochlear implant/s). * Fluent speaker in the language used to assess clinical performance as judged by the investigator. * Willing and able to provide written informed consent. Exclusion Criteria: * Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator. * Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling. * Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation. * Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation). * Women who are pregnant.

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Denver Research and Technology Labs Lone Tree Colorado Completed
HEARnet Clinical Studies Melbourne Victoria Active Not Recruiting
European Institute for Otorhinolaryngology (EIORL) ENT department Sint-Augustinus Antwerp Antwerp Antwerp Recruiting
Hoorzorg van Looveren Wommelgem Antwerp Recruiting

More Cochlear trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06098482 on ClinicalTrials.gov ↗ ← All trials in the USA